RxDoctor Payments Data

Veronica Davis, DO

Internal Medicine · Wesley Chapel, FLNPI 1770743015

Payments from drug & device makers

$6,668in general payments, 2019–2025

Across 432 payments — averaging $15.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AstraZeneca$972
  • Lilly USA, LLC$467
  • AbbVie$333
  • Abbott$301
  • Boehringer Ingelheim$284
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$6,647100%
  • Education$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,668 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$77,646
Medicare patients
155
Services billed
918

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide216$290,783
OzempicSemaglutide53$62,265
JardianceEmpagliflozin35$34,054
RybelsusSemaglutide25$25,224
SynjardyEmpagliflozin/Metformin Hcl26$18,061
EliquisApixaban13$16,411
Repatha SureclickEvolocumab13$12,709
MyrbetriqMirabegron16$8,314
BelsomraSuvorexant13$5,853
Duloxetine Hcl59$4,150
SynthroidLevothyroxine Sodium34$3,377
Atorvastatin Calcium260$2,391
Pantoprazole Sodium72$2,059
Sucralfate11$1,958
Omeprazole77$1,825

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$467$290,783216 claims
Novo NordiskOzempic, Rybelsus$2,848$87,48978 claims
Boehringer IngelheimJardiance, Synjardy$284$52,11461 claims
PfizerEliquis$105$16,41113 claims
MerckBelsomra$95$5,85313 claims
AbbVieSynthroid$333$3,37734 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,530 internal medicine providers in Florida.

Other internal medicine in Wesley Chapel

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →